Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view

A Kronbichler, M Effenberger, M Eisenhut, KH Lee… - Autoimmunity …, 2020 - Elsevier
Now COVID-19 is causing a severe public health emergency and the mortality is rapidly
increasing all over the world. In the current pandemic era, although there have been many …

The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19

AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases

Z Hamidi, S Jabraeili-Siahroud, Y Taati-Alamdari… - Virology Journal, 2023 - Springer
After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

Severe COVID-19: immunosuppression or hyperinflammation?

Y Liu, Y Li, D Xu, J Zhang, Z Peng - Shock, 2021 - journals.lww.com
The ongoing coronavirus disease 2019 (COVID-19) pandemic has swept over the world and
causes thousands of deaths. Although the clinical features of COVID-19 become much …

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

Y Jamilloux, T Henry, A Belot, S Viel, M Fauter… - Autoimmunity …, 2020 - Elsevier
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis

X Feng, S Li, Q Sun, J Zhu, B Chen, M Xiong… - Frontiers in …, 2020 - frontiersin.org
Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from …

W Zhang, Y Zhao, F Zhang, Q Wang, T Li, Z Liu… - Clinical …, 2020 - Elsevier
The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all
over the world. Reports from China showed that about 20% of patients developed severe …

Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach

A Das, S Roy, S Swarnakar, N Chatterjee - Clinical Immunology, 2021 - Elsevier
Abstract In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2), a novel variant of coronavirus has emerged from Wuhan in China and has created havoc …

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Y Rodríguez, L Novelli, M Rojas, M De Santis… - Journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …